INmune Bio, Inc. (INMB)
1.32
-0.03
(-2.22%)
USD |
NASDAQ |
Feb 19, 16:00
1.31
-0.01
(-0.76%)
After-Hours: 07:26
INmune Bio Total Assets (Quarterly) : 33.36M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
| BioMarin Pharmaceutical, Inc. | 7.615B |
| Imunon, Inc. | 8.988M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.98M |
| Shareholders Equity (Quarterly) | 25.38M |
| Debt to Equity Ratio | 0.0426 |
| Current Ratio | 4.169 |
| Net Debt Paydown Yield | 1.58% |